Novamis Biohacking Complex
Ubud, Bali · opening Q2 2027
The strongest offer on the Bali market: high returns and fast payback. A one-of-a-kind project with no equivalent in Bali or anywhere in the world.

- a 1% share
- $40,000
- IRR
- 16-34% from the negative to the positive scenario
- payback
- 3.1-6.2 years from commercial launch
- unique concept
- Biohacking & Wellness
Figures from the Novamis financial model of 9 Nov 2026, negative and positive scenarios, for a 1% share ($40,000). A forecast, not guaranteed income.
The deal step by step
How to become a co-owner of Novamis
Five steps from a sample contract to a named owner certificate.
Step 1 of 5
Sample contract
A standard contract with the Hong Kong structure: a template for review, with no personal data.
Share packages
- Share 1%Entry $40,000
Renders and photos
Construction today
What is on the site
Site footage with a date on every frame. A new series from the same points every month.
shot 16 Feb 2026
- 16 Feb 2026
- 16 Feb 2026
- 16 Feb 2026
- 16 Feb 2026
- 16 Feb 2026
- 16 Feb 2026
- 16 Feb 2026
All site footage, 5 more
- 16 Feb 2026
16 Feb 2026
16 Feb 2026
16 Feb 2026
16 Feb 2026
8 clips and 4 photos from the site.
Money flow
Where your $40,000 goes and how it comes back
Eight links from your transfer to your payout.
- InYour money$40,000
Bank transfer against the invoice to the agreement with the Hong Kong holding
- Project company
HK Co (Hong Kong) owns 90% of PT PMA (Indonesia). The money goes to PT PMA under a shareholder loan agreement
- Construction and launch
Project budget $3.6M: construction 60%, land 20% paid, equipment 20%. 40-year land lease paid. Opening Q2 2027
- Centre revenue
Two streams: residents and programmes for Ubud guests
- resident, per week, double occupancy
- from $5,500
- day-access programme
- $1,000-1,500
- EBITDA$1.30-2.69M
Year 3, negative and positive scenarios, 47.9-56.2% margin
- Before payout
- of EBITDA to the management company Revolt Group Indonesia
- 20%
- of revenue to the reserve fund, separate from investor money
- 2%
- BackYour payout
1% of distributable profit after tax. Quarterly, within 15 days after the report
Profit figures: financial model of 9 Nov 2026, two scenarios, a forecast, not guaranteed income. The agreement confirms the order of deductions.
Financials
Two scenarios, one table
Negative and positive scenarios of the 9 Nov model for a 1% share ($40,000). A base scenario will be added once the financier confirms it.
- IRR
- 16%
- payback from launch
- 6.2 years
- NPV of a 1% share, 11% rate
- $17,587
- IRR
- 34%
- payback from launch
- 3.1 years
- NPV of a 1% share, 11% rate
- $111,837
The third year of the centre
- revenue
- $2.72-4.78M
- EBITDA
- $1.30-2.69M
- EBITDA margin
- 47.9-56.2%
For comparison: Bali villas 7-12% a year, Ubud after costs 7-10%. The Novamis negative scenario: IRR 16%.
Forecast per the financial model of 9 Nov 2026. The result depends on occupancy and prices and is not guaranteed income. Market benchmark: Knight Frank via Rumavi and Bali agency data.
Legal structure and documents
Who owns what
An operating company in Indonesia, a holding in Hong Kong, your agreement under English law.
- PT PMA (Indonesia)
Operating company of the centre: accommodation, therapies, day programmes
- HK Co (Hong Kong)
Owns 90% of PT PMA and receives dividends as the majority shareholder
- Investor
Signs an Assignment of Economic Rights for 1% in Hong Kong
- 40-year land lease paid in full, preferred extension for another 20 years
- Optional notarial reinforcement of the deal, +1% of the amount
- Named owner certificate within 7 days of payment
Team
Who builds and runs it
Revolt Group has delivered three projects in Bali. The Novamis team by name below.

- KonstantinBusiness Development Manager
Why this project
- 01
A wellness & longevity centre in Ubud: 8 therapy zones, 6 resident suites, 1,700 m² of grounds
- 02
Two revenue streams: resident retreats from $5,500 per week and day access at $1,000-1,500
- 03
Year-3 revenue $2.72-4.78M, EBITDA $1.30-2.69M, 47.9-56.2% margin
- 04
Opening in Q2 2027, payouts from Q3 2027. Management fee 20% of EBITDA, reserve fund 2% of revenue
Discuss the deal
We will answer your questions and send the financial model.
Message on WhatsApp
















